fesoterodine inn used fumarate brand name toviaz antimuscarinic drug developed schwarz pharma ag treat overactive bladder syndrome approved european medicines agency april us food drug administration october health canada february fesoterodine prodrug broken active metabolite desfesoterodine plasma esterases fesoterodine advantage allowing flexible dosage muscarinic tolerability side effects similar muscarinic antagonists new drug seems unlikely make great changes practices treatment overactive japanese study showed urgency urge incontinence improved days administration drug full efficacy able judged days administration overactive bladder found resolved patients seven days usage drug article relating genitourinary system stub help wikipedia expanding ithttpsenwikipediaorgwikifesoterodine